TRT Side Effects: What to Watch For and Is It Safe Long Term?

You started testosterone replacement therapy and you feel better. More energy. Better mood. Improved libido. Your gym numbers are up. It seems like a miracle — and you're wondering what the catch is.

There is a catch. Not a dramatic one, not a reason to stop TRT if it's medically indicated, but a real set of side effects and risks that require ongoing monitoring. Too many men start testosterone, feel great, and then coast without blood work for months or years. Too many clinics prescribe it and never follow up. This is how preventable complications happen.

Here's what you need to monitor and why.

The Most Common Side Effect: Polycythemia

Testosterone stimulates erythropoiesis — red blood cell production. In most men, this is a modest increase. In some, it's excessive, leading to polycythemia (elevated hematocrit and hemoglobin).

Why it matters: Thick blood increases the risk of stroke, deep vein thrombosis, pulmonary embolism, and other thromboembolic events. This is the most dangerous common side effect of TRT.

Numbers to know:

• Hematocrit above 50% requires attention
• Hematocrit above 54% typically requires intervention (dose reduction, blood donation, therapeutic phlebotomy, or switching from injections to topical formulations)

How to manage:

• Check CBC at baseline, 3 months, 6 months, then every 6-12 months
• If elevated, consider dose reduction first
• Switch delivery method — injections (especially high-dose, infrequent IM injections) cause more polycythemia than daily topical gels or patches due to supraphysiologic peaks
• Therapeutic phlebotomy (essentially blood donation) reduces hematocrit
• Stay hydrated — dehydration concentrates blood and worsens hematocrit readings

At CORAL, Dr. Kim monitors hematocrit at every lab check and adjusts treatment proactively to prevent levels from reaching dangerous ranges.

Cardiovascular Risk: What the Evidence Says

This has been the most debated aspect of TRT for over a decade. The current evidence:

The TRAVERSE trial (2023) — The largest and most definitive cardiovascular safety trial for TRT. 5,246 men ages 45-80 with hypogonadism and established or high-risk cardiovascular disease. Testosterone gel vs. placebo for a median of 33 months. Result: testosterone did NOT increase the rate of major adverse cardiovascular events. This was a non-inferiority trial, and it met its endpoint.

What this means: TRT at physiological replacement doses does not appear to increase cardiovascular risk in men with hypogonadism. Earlier studies that suggested harm had significant methodological limitations (observational design, mixed populations, lack of testosterone level monitoring).

What it doesn't mean: TRT is not cardiovascular protection. The TRAVERSE trial showed safety, not benefit. And supraphysiologic doses (bodybuilder-level testosterone) were not studied and may carry different risks.

Monitoring implications:

• Lipid panel at baseline and periodically — TRT can modestly decrease HDL
• Blood pressure monitoring — TRT can cause mild fluid retention
• Cardiovascular symptom awareness — chest pain, shortness of breath, leg swelling

PSA and Prostate Health

The old fear was that TRT "causes" prostate cancer. The current evidence does not support this:

What we know:

• TRT modestly increases PSA (typically 0.3-0.5 ng/mL in the first 6-12 months)
• TRT does not increase the incidence of prostate cancer in clinical trials, including TRAVERSE
• Androgen deprivation therapy (ADT) is used to treat prostate cancer because prostate cancer is androgen-sensitive — but that doesn't mean normal testosterone causes cancer
• The "saturation model" explains this: prostate tissue androgen receptors are saturated at relatively low testosterone levels. Increasing testosterone above the saturation point doesn't further stimulate prostate growth.

Monitoring requirements:

• Baseline PSA before starting TRT
• PSA at 3-6 months, then annually
• If PSA increases more than 1.4 ng/mL from baseline within 12 months, or velocity exceeds 0.4 ng/mL/year, further evaluation (urology referral) is warranted
• Digital rectal exam at baseline and periodically per age-appropriate screening guidelines

Contraindications:

• Known prostate cancer (most guidelines still consider this a contraindication, though emerging research is challenging this)
• Elevated PSA without completed evaluation
• Severe BPH symptoms (relative contraindication — TRT can worsen lower urinary tract symptoms in some men)

Fertility Impact: The Hidden Consequence

This is arguably the most important side effect, and the most poorly communicated. Exogenous testosterone suppresses spermatogenesis. In many men, TRT functions as male contraception.

Here's the mechanism: when you inject or apply testosterone, your hypothalamus and pituitary detect the elevated levels and shut down production of GnRH, LH, and FSH. Without LH and FSH, your testes stop producing both testosterone AND sperm. Testicular atrophy (shrinkage) follows.

Key facts:

• Sperm count drops to zero or near-zero in most men on TRT within 3-6 months
• Recovery of spermatogenesis after stopping TRT is probable but not guaranteed — it can take 6-24 months
• Roughly 5-10% of men may have incomplete recovery of sperm production
• The longer you're on TRT, the less certain recovery becomes

If you want children:

• TRT is NOT appropriate if you're actively trying to conceive
• Alternatives exist: clomiphene citrate, hCG (human chorionic gonadotropin), or enclomiphene stimulate your own testosterone production without suppressing sperm production
• If you're on TRT and want to preserve fertility, adding hCG (250-500 IU 2-3 times weekly) to your TRT regimen can maintain some spermatogenesis and prevent testicular atrophy
• Consider semen analysis and possibly sperm banking before starting TRT

Other Side Effects

Acne — Testosterone increases sebum production. Usually mild. Manageable with standard acne treatments. More common with injections than topicals.

Sleep apnea — TRT may worsen existing obstructive sleep apnea. Screen for sleep apnea before starting TRT (snoring, daytime sleepiness, witnessed apneas). If present, treat with CPAP before or simultaneously with TRT.

Mood and behavioral effects — Some men experience irritability, aggression, or mood swings, especially with high-dose injection regimens that create supraphysiologic peaks. More frequent, lower-dose injections or topical formulations provide more stable levels.

Gynecomastia — Testosterone can be converted to estradiol by aromatase. If estradiol rises excessively, breast tissue growth can occur. Monitoring estradiol and adjusting dose or adding an aromatase inhibitor (anastrozole) can manage this.

Fluid retention — Mild weight gain from water retention is common initially. Usually stabilizes.

Skin reactions — With topical gels: irritation at application site. With injections: occasional injection site pain or nodule formation.

The Essential Lab Schedule

Here's the monitoring schedule Dr. Kim follows at CORAL for men on TRT:

Baseline (before starting):

• Total and free testosterone (morning draw)
• CBC (hematocrit baseline)
• Comprehensive metabolic panel
• Lipid panel
• PSA
• Estradiol
• LH, FSH
• Semen analysis if fertility is a concern

3-month follow-up:

• Total and free testosterone (trough level — morning before next injection, or anytime for topicals)
• CBC (hematocrit is the critical value)
• PSA
• Estradiol
• Liver function (if not included in CMP)

6-month follow-up:

• Same as 3-month panel
• Lipid panel
• Metabolic panel

Ongoing (every 6-12 months):

• Testosterone levels, CBC, PSA, estradiol, lipids, metabolic panel
• Adjust frequency based on stability and any abnormalities

The Bottom Line

TRT is safe and effective when properly monitored. The key word is "monitored." Clinics that prescribe testosterone without regular lab work, or that chase supraphysiologic levels without tracking side effects, are putting you at unnecessary risk.

If you're on TRT and haven't had blood work in the last 6 months — or if you started TRT without a complete baseline evaluation — [schedule a visit at coral.clinic/start](https://coral.clinic/start). Dr. Kim provides evidence-based TRT management with the monitoring schedule your health requires.